With the threat of COVID-19 still looming in many communities across the U.S. and uncertainty over its future path, now more than ever, it's critical for people to get a flu shot.
Several drugmakers are already stockpiling drugs in case of a no-deal Brexit. However, one crucial product simply cannot be reserved because it’s not possible to be made in advance: the seasonal flu vaccine.
As flu-vaccine heavyweights dispatch their first doses for the upcoming season, they're planning millions more doses made with next-generation production processes, rather than traditional egg-based manufacturing.